Compounds > ly 274614
Page last updated: 2024-09-03

ly 274614 and Drug Withdrawal Symptoms

ly 274614 has been researched along with Drug Withdrawal Symptoms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gewirtz, JC; Rothwell, PE; Thomas, MJ1
Gomez, T; Raffa, RB; Rawls, SM1
Barr, GA; Du, T; Inturrisi, CE; Jenab, S; Jones, KL; Zhu, H1
Brodsky, M; Inturrisi, CE; Rasmussen, K1
Fuller, RW; Ornstein, PL; Perry, KW; Rasmussen, K; Stockton, ME; Swinford, RM1

Other Studies

5 other study(ies) available for ly 274614 and Drug Withdrawal Symptoms

ArticleYear
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:10

    Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Conditioning, Operant; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Isoquinolines; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Propranolol; Rats; Rats, Sprague-Dawley; Reflex, Startle; Substance Withdrawal Syndrome; Time Factors

2009
An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2).
    Pharmacology, biochemistry, and behavior, 2007, Volume: 86, Issue:3

    Topics: Animals; Benzoxazines; Cannabinoids; Isoquinolines; Marijuana Abuse; Morpholines; Motor Activity; Naphthalenes; Planarians; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome

2007
Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2002, Volume: 26, Issue:3

    Topics: Analgesics, Opioid; Animals; Animals, Newborn; Behavior, Animal; Binding, Competitive; Brain; Excitatory Amino Acid Antagonists; Female; Isoquinolines; Male; Morphine; Pregnancy; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Spinal Cord; Substance Withdrawal Syndrome

2002
NMDA antagonists and clonidine block c-fos expression during morphine withdrawal.
    Synapse (New York, N.Y.), 1995, Volume: 20, Issue:1

    Topics: Animals; Clonidine; Dizocilpine Maleate; Gene Expression; Genes, fos; In Vitro Techniques; Isoquinolines; Male; Morphine; Naltrexone; Neural Pathways; Nucleic Acid Hybridization; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA Probes; RNA, Messenger; Substance Withdrawal Syndrome

1995
NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
    European journal of pharmacology, 1991, May-02, Volume: 197, Issue:1

    Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Electrophysiology; Isoquinolines; Locus Coeruleus; Male; Morphine; Naltrexone; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome

1991